tiprankstipranks
Avalo Therapeutics (AVTX)
NASDAQ:AVTX
US Market
AVTX
Avalo Therapeutics
RESEARCH TOOLSreports

Avalo Therapeutics (AVTX) Balance Sheet

1,048 Followers

Avalo Therapeutics Balance Sheet

Avalo Therapeutics's total assets for Q4 2025 were $116.46M, a decrease of -6.91% from the previous quarter. AVTX total liabilities were $33.41M for the fiscal quarter, a -0.43% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 116.46M$ 150.73M$ 20.99M$ 33.37M$ 80.21M
Total Liabilities
$ 33.41M$ 17.70M$ 13.69M$ 44.28M$ 57.13M
Total Equity Gross Minority
$ 83.05M$ 133.03M$ 7.30M$ -10.91M$ 23.08M
Other Metrics
Currency in USD

Avalo Therapeutics Debt to Assets